Minocycline reduces remyelination by suppressing ciliary neurotrophic factor expression after cuprizone-induced demyelination

Journal of Neurochemistry

Volumn 127, Issue 2, 2013, Pages 259-270

  Tanaka, Tatsuhide ^a   Murakami, Koichi ^a   Bando, Yoshio ^a   Yoshida, Shigetaka ^a  

^a ASAHIKAWA MEDICAL COLLEGE   (Japan)

Author keywords

CNTF; cuprizone; demyelination; microglia; minocycline; remyelination

Indexed keywords

2',3' CYCLIC NUCLEOTIDE 3' PHOSPHODIESTERASE; CILIARY NEUROTROPHIC FACTOR; CUPRIZONE; MESSENGER RNA; MINOCYCLINE; MYELIN BASIC PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; BRAIN REGION; CONTROLLED STUDY; CORPUS CALLOSUM; DEMYELINATION; DISEASE ASSOCIATION; DRUG EFFECT; DRUG MECHANISM; FEMALE; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REMYELINIZATION;

CNTF; CUPRIZONE; DEMYELINATION; MICROGLIA; MINOCYCLINE; REMYELINATION;

ANIMALS; ANTI-BACTERIAL AGENTS; BLOTTING, WESTERN; CELLS, CULTURED; CILIARY NEUROTROPHIC FACTOR; CORPUS CALLOSUM; CUPRIZONE; DEMYELINATING DISEASES; FEMALE; IMMUNOHISTOCHEMISTRY; MICE; MICE, INBRED C57BL; MICROGLIA; MINOCYCLINE; MONOAMINE OXIDASE INHIBITORS; MYELIN BASIC PROTEIN; MYELIN SHEATH; OLIGODENDROGLIA; REAL-TIME POLYMERASE CHAIN REACTION;

MURINAE; MUS;

EID: 84885427490     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/jnc.12289     Document Type: Article

References (36)

1. Albrecht P. J., Murtie J. C., Ness J. K., Redwine J. M., Enterline J. R., Armstrong R. C., and, Levison S. W., (2003) Astrocytes produce CNTF during the remyelination phase of viral-induced spinal cord demyelination to stimulate FGF-2 production. Neurobiol. Dis. 13, 89-101.
2. Albrecht P. J., Enterline J. C., Cromer J., and, Levison S. W., (2007) CNTF-activated astrocytes release a soluble trophic activity for oligodendrocyte progenitors. Neurochem. Res. 32, 263-271.
3. Althaus H. H., Klöppner S., Klopfleisch S., and, Schmitz M., (2008) Oligodendroglial cells and neurotrophins: a polyphonic cantata in major and minor. J. Mol. Neurosci. 35, 65-79.
4. Cai Z. Y., Yan Y., and, Chen R., (2010) Minocycline reduces astrocytic reactivation and neuroinflammation in the hippocampus of a vascular cognitive impairment rat model. Neurosci. Bull. 26, 28-36.
5. David S., and, Kroner A., (2011) Repertoire of microglial and macrophage responses after spinal cord injury. Nat. Rev. Neurosci. 12, 388-399.
6. Defaux A., Zurich M. G., Honegger P., and, Monnet-Tschudi F., (2011) Minocycline promotes remyelination in aggregating rat brain cell cultures after interferon-γ plus lipopolysaccharide-induced demyelination. Neuroscience 187, 84-92.
7. Dubois-Dalcq M., Ffrench-Constant C., and, Franklin R. J., (2005) Enhancing central nervous system remyelination in multiple sclerosis. Neuron 48, 9-12.
8. Dutta R., and, Trapp B. D., (2011) Mechanisms of neuronal dysfunction and degeneration in multiple sclerosis. Prog. Neurobiol. 93, 1-12.
9. Franklin R. J., (2002) Why does remyelination fail in multiple sclerosis? Nat. Rev. Neurosci. 3, 705-714.
10. Gudi V., Škuljec J., Yildiz Ö., Frichert K., Skripuletz T., Moharregh-Khiabani D., Voss E., Wissel K., Wolter S., and, Stangel M., (2011) Spatial and temporal profiles of growth factor expression during CNS demyelination reveal the dynamics of repair priming. PLoS ONE 6, e22623.
11. Hanisch U. K., and, Kettenmann H., (2007) Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat. Neurosci. 10, 1387-1394.
12. Herrmann I., Kellert M., Spreer A., Gerber J., Eiffert H., Prinz M., and, Nau R., (2007) Minocycline delays but does not attenuate the course of experimental autoimmune encephalomyelitis in Streptococcus pneumoniae-infected mice. J. Antimicrob. Chemother. 59, 74-79.
13. Kipp M., Clarner T., Dang J., Copray S., and, Beyer C., (2009) The cuprizone animal model: new insights into an old story. Acta Neuropathol. 118, 723-736.
14. Kotter M. R., Zhao C., van Rooijen N., and, Franklin R. J., (2005) Macrophases-depletion induced impairment of experimental CNS remyelination is associated with a reduced oligodendrocyte progenitor cell response and altered growth factor expression. Neurobiol. Dis. 18, 166-175.
15. Kreutzberg G. W., (1996) Microglia: a sensor for pathological events in the CNS. Trends Neurosci. 19, 312-318.
16. Kuhlmann T., Miron V., Cui Q., Wegner C., Antel J., and, Brück W., (2008) Differentiation block of oligodendroglial progenitor cells as a cause for remyelination failure in chronic multiple sclerosis. Brain 131, 1749-1758.
17. Li W. W., Setzu A., Zhao C., and, Franklin R. J., (2005) Minocycline-mediated inhibition of microglia activation impairs oligodendrocyte progenitor cell responses and remyelination in a non-immune model of demyelination. J. Neuroimmunol. 158, 58-66.
18. Linker R. A., Mäurer M., Gaupp S., et al,. (2002) CNTF is a major protective factor in demyelinating CNS disease: a neurotrophic cytokine as modulator in neuroinflammation. Nat. Med. 8, 620-624.
19. Lu Z., Hu X., Zhu C., Wang D., Zheng X., and, Liu Q., (2009) Overexpression of CNTF in Mesenchymal Stem Cells reduces demyelination and induces clinical recovery in experimental autoimmune encephalomyelitis mice. J. Neuroimmunol. 206, 58-69.
20. Mason J. L., Suzuki K., Chaplin D. D., and, Matsushima G. K., (2001) Interleukin-1 beta promotes repair of the CNS. J. Neurosci. 21, 7046-7052.
21. Matsushima G. K., and, Morell P., (2001) The neurotoxicant, cuprizone, as a model to study demyelination and remyelination in the central nervous system. Brain Pathol. 11, 107-116.
22. Mayer M., Bhakoo K., and, Noble M., (1994) Ciliary neurotrophic factor and leukemia inhibitory factor promote the generation, maturation and survival of oligodendrocytes in vitro. Development 120, 143-153.
23. Miller R. H., and, Mi S., (2007) Dissecting demyelination. Nat. Neurosci. 10, 1351-1354.
24. Moore C. S., Abdullah S. L., Brown A., Arulpragasam A., and, Crocker S. J., (2011) How factors secreted from astrocytes impact myelin repair. J. Neurosci. Res. 89, 13-21.
25. Nash B., Thomson C. E., Linington C., Arthur A. T., McClure J. D., McBride M. W., and, Barnett S. C., (2011) Functional duality of astrocytes in myelination. J. Neurosci. 31, 13028-13038.
26. Olah M., Amor S., Brouwer N., Vinet J., Eggen B., Biber K., and, Boddeke H. W., (2012) Identification of a microglia phenotype supportive of remyelination. Glia 60, 306-321.
27. Orazizadeh M., Hashemitabar M., and, Khorsandi L., (2009) Protective effect of minocycline on dexamethasone induced testicular germ cell apoptosis in mice. Eur. Rev. Med. Pharmacol. Sci. 13, 1-5.
28. Pasquini L. A., Calatayud C. A., Bertone Uña A. L., Millet V., Pasquini J. M., and, Soto E. F., (2007) The neurotoxic effect of cuprizone on oligodendrocytes depends on the presence of pro-inflammatory cytokines secreted by microglia. Neurochem. Res. 32, 279-292.
29. Schmitz T., and, Chew L. J., (2008) Cytokines and myelination in the central nervous system. ScientificWorldJournal 8, 1119-1147.
30. Schmitz T., Endesfelder S., Chew L. J., Zaak I., and, Bührer C., (2012) Minocycline protects oligodendroglial precursor cells against injury caused by oxygen-glucose deprivation. J. Neurosci. Res. 90, 933-944.
31. Skripuletz T., Miller E., Moharregh-Khiabani D., Blank A., Pul R., Gudi V., Trebst C., and, Stangel M., (2010) Beneficial effects of minocycline on cuprizone induced cortical demyelination. Neurochem. Res. 35, 1422-1433.
32. Stankoff B., Aigrot M. S., Noël F., Wattilliaux A., Zalc B., and, Lubetzki C., (2002) Ciliary neurotrophic factor (CNTF) enhances myelin formation: a novel role for CNTF and CNTF-related molecules. J. Neurosci. 22, 9221-9227.
33. Stöckli K. A., Lottspeich F., Sendtner M., Masiakowski P., Carroll P., Götz R., Lindholm D., and, Thoenen H., (1989) Molecular cloning, expression and regional distribution of rat ciliary neurotrophic factor. Nature 342, 920-923.
34. Tanaka T., Ueno M., and, Yamashita T., (2009) Engulfment of axon debris by microglia requires p38 MAPK activity. J. Biol. Chem. 284, 21626-21636.
35. Van der Valk P., and, De Groot C. J., (2000) Staging of multiple sclerosis (MS) lesion: pathology of the time frame of MS. Neuropathol. Appl. Neurobiol. 26, 2-10.
36. Yin X., Peterson J., Gravel M., Braun P. E., and, Trapp B. D., (1997) CNP overexpression induces aberrant oligodendrocyte membranes and inhibits MBP accumulation and myelin compaction. J. Neurosci. Res. 50, 238-247.